Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	The Journal of Infection in Developing Countries 2024-05-01
Saila:	Journal of Infection in Developing Countries
Gaiak:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
Sarrera elektronikoa:	https://jidc.org/index.php/journal/article/view/18410
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!